Clinical Trials on Refractory Low Grade Glioma in France
Total 83 results
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 GliomaUnited States, Canada
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedRefractory Low-grade Gliomas | Recurrent Low-grade GliomasAustria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisInnovative Therapies For Children with Cancer ConsortiumTerminatedRefractory Low-grade Gliomas | Recurrent Low-grade GliomasAustria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
-
National Cancer Institute (NCI)RecruitingLow Grade Glioma | Low Grade Astrocytoma | Metastatic Low Grade Astrocytoma | Metastatic Low Grade GliomaUnited States, Canada, Puerto Rico
-
Hospices Civils de LyonTerminatedLow Grade Glioma (LGG), High Grade Glioma (HGG)France
-
Hospices Civils de LyonCompletedLow Grade Glioma (LGG) | High Grade Glioma (HGG)France
-
University Hospital, MontpellierUnknown
-
University Hospital, ToulouseCompleted
-
University Hospital, MontpellierNational Development and Research Institutes, Inc.Active, not recruiting
-
University Hospital, MontpellierCompletedLow-grade GliomaFrance
-
Centre Oscar LambretNational Cancer Institute, France; Pierre Fabre LaboratoriesCompleted
-
Day One Biopharmaceuticals, Inc.SIOPe Brain Tumor Group LOGGIC ConsortiumRecruitingLow-grade GliomaUnited States, Korea, Republic of, France, Germany, Spain, United Kingdom, Belgium, Denmark, Canada, Italy, Finland, Australia, Ireland, Switzerland, Netherlands, Czechia, Greece, New Zealand, Slovenia, Sweden, Hungary, Singapore, A... and more
-
University Hospital, ToursCompletedMotor Disorders | Low-grade Glioma | Cognitive DisordersFrance
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
European Organisation for Research and Treatment...Cooperative Trials Group for Neuro-Oncology (COGNO)TerminatedTemozolomide | Low-grade Glioma | Phase III | Wait or TreatSpain, Australia, Switzerland, France, Belgium, Italy, Austria, Netherlands, United Kingdom, Denmark
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingMultiple Sclerosis | Low Grade Glioma of Brain | Sexual DysfunctionsFrance
-
Hospices Civils de LyonRecruitingOligodendroglioma | Low-grade Oligodendroglioma | 1p19q CodeletionFrance
-
University Hospital, GrenobleNational Cancer Institute, FranceTerminated
-
University Hospital, BordeauxCompletedGlioblastoma | Astrocytoma | High-grade GliomaFrance
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
University Hospital, AngersAssistance Publique - Hôpitaux de Paris; National Cancer Institute, FranceUnknownHealthy Volunteers | Medulloblastoma, Childhood | Low-grade Glioma | Fossa Posterior TumorFrance
-
University Hospital, Strasbourg, FranceRecruitingPleomorphic Xanthoastrocytoma | Grade 1 Glioma | Mixed Glio-neuronal TumorsFrance
-
Central Hospital, Nancy, FranceRecruitingHigh Grade GliomaFrance
-
Hospices Civils de LyonCompleted
-
Institut CurieTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedBarrett Oesophagus | Low Grade DysplasiaFrance
-
French Innovative Leukemia OrganisationCompleted
-
Clinique Beau SoleilCepheid; Team Languedoc Mutualité / Nouvelles technologiesCompletedNon-Invasive Bladder Urothelial Carcinoma | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeFrance
-
University Hospital, BordeauxTerminatedLow Anterior Resection Syndrome (LARS>20) | Refractory Medical Treatment After Rectal ResectionFrance
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRefractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma and other conditionsUnited States, Puerto Rico, Australia
-
Institut Cancerologie de l'OuestHospices Civils de Lyon; Centre Antoine LacassagneTerminatedGlioblastoma | Grade IV AstrocytomaFrance
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | WHO Grade 3 Glioma | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Glioma | Recurrent Cholangiocarcinoma | WHO Grade 2 GliomaUnited States
-
CSA Medical, Inc.TerminatedBarrett's Esophagus | Low Grade Dysplasia | High Grade DysplasiaUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Langerhans Cell Histiocytosis | Recurrent Lymphoma | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant... and other conditionsUnited States, Puerto Rico, Australia
-
Institut de Recherches Internationales ServierActive, not recruitingRecurrent Glioma | Grade 2 Glioma | Residual GliomaUnited States, Canada, Spain, Italy, United Kingdom, Switzerland, Israel, Japan, Netherlands, Germany, France
-
Hoffmann-La RocheCompletedHigh Grade GliomaUnited Kingdom, Canada, Austria, Italy, Spain, Sweden, Belgium, Denmark, France, Australia, Czechia, Hungary, Netherlands, Poland
-
Poitiers University HospitalRecruitingClinical | Development of the Virtual Biopsy | Tumor Grade | Artificial Intelligence Algorithms | RadiologicalFrance
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Recurrent Melanoma | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
Centre Leon BerardMinistry of Health, FranceTerminated
-
Assistance Publique - Hôpitaux de ParisBristol-Myers SquibbCompletedBrain Cancer | High Grade GliomaFrance
-
The Lymphoma Academic Research OrganisationLymphoma Study AssociationNot yet recruitingRefractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaFrance
-
European Organisation for Research and Treatment...Tragara Pharmaceuticals, Inc.CompletedGlioblastoma | Astrocytoma, Grade IIIFrance, Austria, Germany, Netherlands, Switzerland
-
Daniela A. BotaNovoCure Ltd.Active, not recruitingAstrocytoma, Grade IIIUnited States
-
National Cancer Institute (NCI)Active, not recruitingAstrocytoma, IDH-Mutant, Grade 2 | Astrocytoma, IDH-Mutant, Grade 3United States
-
National Cancer Institute (NCI)CompletedCervical Cancer | High-grade Squamous Intraepithelial Lesion | Atypical Squamous Cells of Undetermined Significance | Low-grade Squamous Intraepithelial LesionUnited States
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | WHO Grade 3 GliomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)RecruitingRecurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis Type 1 | Low Grade Glioma | Visual Pathway GliomaUnited States, Canada, Puerto Rico